about
JNKK1 organizes a MAP kinase module through specific and sequential interactions with upstream and downstream components mediated by its amino-terminal extensionBS69, a specific adaptor in the latent membrane protein 1-mediated c-Jun N-terminal kinase pathwayp38 and extracellular signal-regulated kinases regulate the myogenic program at multiple stepsMolecular cloning and characterization of human JNKK2, a novel Jun NH2-terminal kinase-specific kinaseThe 8-kDa dynein light chain binds to p53-binding protein 1 and mediates DNA damage-induced p53 nuclear accumulationAxin stimulates p53 functions by activation of HIPK2 kinase through multimeric complex formationPax3/7BP is a Pax7- and Pax3-binding protein that regulates the proliferation of muscle precursor cells by an epigenetic mechanismTRAF6 promotes myogenic differentiation via the TAK1/p38 mitogen-activated protein kinase and Akt pathways.Loss of STAT1 in bone marrow-derived cells accelerates skeletal muscle regeneration.p150(Glued), Dynein, and microtubules are specifically required for activation of MKK3/6 and p38 MAPKs.Oxidation-induced intramolecular disulfide bond inactivates mitogen-activated protein kinase kinase 6 by inhibiting ATP binding.Oncostatin M inhibits myoblast differentiation and regulates muscle regeneration.A novel mechanism of control of NFκB activation and inflammation involving A2B adenosine receptorsKeratin K18 increases cystic fibrosis transmembrane conductance regulator (CFTR) surface expression by binding to its C-terminal hydrophobic patch.Cyclin G2 inhibits epithelial-to-mesenchymal transition by disrupting Wnt/β-catenin signalingmiR-203, a tumor suppressor frequently down-regulated by promoter hypermethylation in rhabdomyosarcoma.p38 Mitogen-activated protein kinase-, calcium-calmodulin-dependent protein kinase-, and calcineurin-mediated signaling pathways transcriptionally regulate myogenin expression.Expression of Gα(z) in C2C12 cells restrains myogenic differentiation.Role of mitogen-activated protein kinase in Zn-BC-AM PDT-induced apoptosis in nasopharyngeal carcinoma cells.JAK1-STAT1-STAT3, a key pathway promoting proliferation and preventing premature differentiation of myoblasts.SOCS1, SOCS3, and PIAS1 promote myogenic differentiation by inhibiting the leukemia inhibitory factor-induced JAK1/STAT1/STAT3 pathway.Involvement of the p38 mitogen-activated protein kinase alpha, beta, and gamma isoforms in myogenic differentiation.Isolation and characterization of a novel oncogene, amplified in liver cancer 1, within a commonly amplified region at 1q21 in hepatocellular carcinoma.BS69 is involved in cellular senescence through the p53-p21Cip1 pathway.Sequential recruitment of PCAF and BRG1 contributes to myogenin activation in 12-O-tetradecanoylphorbol-13-acetate-induced early differentiation of rhabdomyosarcoma-derived cells.Differential requirement of MKK4 and MKK7 in JNK activation by distinct scaffold proteins.Myostatin induces cyclin D1 degradation to cause cell cycle arrest through a phosphatidylinositol 3-kinase/AKT/GSK-3 beta pathway and is antagonized by insulin-like growth factor 1.Latent membrane protein 1 suppresses RASSF1A expression, disrupts microtubule structures and induces chromosomal aberrations in human epithelial cells.Molecular and cytogenetic changes involved in the immortalization of nasopharyngeal epithelial cells by telomerase.Myocyte enhancer factor 2 acetylation by p300 enhances its DNA binding activity, transcriptional activity, and myogenic differentiation.Akt binds prohibitin 2 and relieves its repression of MyoD and muscle differentiation.The insulin-like growth factor-phosphatidylinositol 3-kinase-Akt signaling pathway regulates myogenin expression in normal myogenic cells but not in rhabdomyosarcoma-derived RD cells.Label-free multimodal nonlinear optical microscopy reveals fundamental insights of skeletal muscle development.JAK2/STAT2/STAT3 are required for myogenic differentiation.Tyk2/STAT3 signaling mediates beta-amyloid-induced neuronal cell death: implications in Alzheimer's disease.Nerve growth factor-induced differentiation of PC12 cells is accompanied by elevated adenylyl cyclase activity.Characterization of cytokine/chemokine profiles of severe acute respiratory syndrome.The involvement of calcineurin in acetylcholine receptor redistribution in muscle.Stabilization of interleukin-2 mRNA by the c-Jun NH2-terminal kinase pathway.Differential and synergistic effect of nerve growth factor and cAMP on the regulation of early response genes during neuronal differentiation.
P50
Q22007973-C63248FC-259F-45F7-9607-806A95A3C1EBQ24537608-9772B117-3050-4487-86B5-A4B045E65F22Q24554203-034818DF-A0D6-435C-93BA-F847AB7FAC67Q24643910-C42A0360-F3C8-4D90-8951-473CC550C84FQ28299353-5112AF0D-D16F-48BC-A2BA-B451471FC1A0Q28587574-019A4A19-87B1-4C02-BBE2-86039B8EFB6AQ28588712-B2AC31B1-1B7E-402E-AA8B-54CE5F8E3C43Q34229995-1648BF38-3DEF-484A-8D5C-6B81AAD55D09Q34287564-0C2B9E32-13F4-4572-8F72-3A1CA15ACAC9Q34349270-CBB18470-DD5F-43E9-BE17-1425963CD082Q34397394-050D4D08-AAF0-455D-A715-1DFD77CD65E9Q35348145-486F5CD0-E849-4CA2-8B6D-C29F3297BCB0Q36407312-8A588AFE-25C0-4D89-BCE7-F839243F1193Q36418881-10EC325F-E8FC-45A4-9509-2490816C3A4FQ37257711-5EF3901B-D6A4-4FCE-A836-36CAA3AFC955Q37428692-32424CCC-7678-4A3E-B160-097C57AB8D9DQ38288277-9B8A6CB9-97F5-4FBF-8C4E-20177EC77AC9Q39644108-7309D131-C77E-4559-922F-77AAD411C9ACQ39717681-9B1E9653-5526-4A66-820C-28C443A40923Q39751478-97E94D93-9FB2-47C6-91E6-D7F1ABAF50EDQ39822876-EC94C0E6-88F1-4D20-85D5-54E70DFE10B3Q40015711-7B513ABE-FF2D-42AA-8F7B-898B88DE57FCQ40049355-A00EE646-32DB-4A26-8E19-290730B2CF53Q40089139-C5F78AB2-87ED-4C00-899A-01F3332B6C72Q40139331-1A9F91CB-CCCB-4F6E-98D0-4D7C3BAE9C1BQ40190672-CAFB3066-EB40-4686-B75F-28BC23679FE8Q40203967-D20FF9C8-E59A-454A-965F-47345388E780Q40209246-3890EC86-B04B-4D65-AB8A-9269AC5AE458Q40281326-E728F465-020E-4CAA-9BC1-28C722BBC59DQ40435172-15ED449D-86AB-4956-AAAC-7727BB8ABCFAQ40549892-BC12B39B-3435-4AFC-94C5-303D4D3F1BCBQ40749592-400B4AA0-66DB-4E7D-BD16-D29356C901ECQ41870814-272D6D21-E54A-45FE-B5A2-D5FC548FCA74Q42089548-D10D387D-61A6-4811-AE21-FAFEAE7BC68CQ43059453-878E6CDE-EFD3-432B-B733-29BCE985CA67Q43100799-BF39D037-6136-479C-BF82-4A7EB093D548Q43823864-4082DFE7-DC83-4F27-A8CE-72A3F2B46ACFQ44558653-31C084C1-D785-4705-AA95-8379AC0CE2F2Q45943250-1558CB08-232B-462F-AA1D-138693E38397Q46142147-A46978ED-CCD0-4DD8-BFD9-25F76606F574
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Zhenguo Wu
@ast
Zhenguo Wu
@en
Zhenguo Wu
@es
Zhenguo Wu
@nl
Zhenguo Wu
@sl
type
label
Zhenguo Wu
@ast
Zhenguo Wu
@en
Zhenguo Wu
@es
Zhenguo Wu
@nl
Zhenguo Wu
@sl
altLabel
鄔振國
@en
prefLabel
Zhenguo Wu
@ast
Zhenguo Wu
@en
Zhenguo Wu
@es
Zhenguo Wu
@nl
Zhenguo Wu
@sl
P106
P1153
8218909600
P31
P496
0000-0003-3049-8324